What type of lung cancer is Vizimpro used to treat?
Medically reviewed by Drugs.com Last updated on Nov 7, 2018.
Official Answer
by Drugs.comVizimpro is taken for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
Vizimpro (dacomitinib) from Pfizer is an oral, once-daily kinase inhibitor that targets two lung cancer biomarkers, both detected by an FDA-approved test. These two targets are:- Epidermal growth factor receptor (EGFR) exon 19 deletion mutations
- EGFR exon 21 L858R substitution mutations.
Other EGFR inhibitors that may be used in the treatment of NSCLC include:
Related Medical Questions
- Oxycodone vs hydrocodone - What's the difference between them?
- What type of cancer is Tecentriq used to treat?
- Vicodin vs Percocet: What's the difference?
- What type of cancer is Rubraca used to treat?
- What drugs are contained in Vyxeos?
- What type of prostate cancer is Erleada used to treat?
- What are the side effects of marijuana?
Drug Information
Related Support Groups
- Dacomitinib
- Vizimpro
- Cancer (158 questions, 591 members)
- Non-Small Cell Lung Cancer (12 questions, 60 members)
- Lung Cancer
